What is POC Pharma?
POC Pharma operates as a specialized SaaS provider dedicated to the pharmacy channel, offering a comprehensive suite of tools for customer engagement, treatment recommendations, and multichannel commercialization. Founded in 2019, the company bridges the gap between pharmaceutical manufacturers and pharmacy stakeholders, ensuring that treatment protocols are delivered with precision and efficiency. By integrating data-driven insights into the pharmacy workflow, POC Pharma enables more effective commercialization strategies, ultimately improving patient outcomes and operational performance for its clients. Its market position is defined by its ability to navigate the highly regulated pharmaceutical environment while providing agile, scalable software solutions.
How much funding has POC Pharma raised?
POC Pharma has raised a total of $4.5M across 1 funding round:
Angel/Seed
$4.5M
Angel/Seed (2021): $4.5M with participation from FJ Labs, 500 Global, FEBE Ventures, Goat Capital, and Picus Capital
Key Investors in POC Pharma
FJ Labs
FJ Labs specializes in angel investing at a venture scale, focusing on marketplaces and network effect businesses with a massive portfolio of unicorn-status startups.
500 Global
A prominent venture capital firm headquartered in California that invests in early-stage companies across the globe to foster innovation.
FEBE Ventures
A seed-focused venture capital firm founded by ex-founders that provides both financial backing and operational insights to startups in emerging markets.
What's next for POC Pharma?
With the recent infusion of capital, POC Pharma is poised to scale its operations and deepen its market penetration. The strategic focus will likely center on enhancing its proprietary recommendation engine and expanding its footprint across key regional markets. As the pharmacy sector continues to undergo rapid digital transformation, POC Pharma is strategically aligned to capitalize on the growing demand for integrated commercialization platforms. Future growth will be driven by the continued adoption of its SaaS model, which provides the necessary agility for stakeholders to adapt to evolving regulatory and market conditions. The company remains focused on long-term value creation, leveraging its strong investor backing to solidify its leadership in the pharmacy technology space.
See full POC Pharma company page
